Serological response to nifurtimox in adult patients with chronic Chagas disease: An observational comparative study in Argentina
Nifurtimox is indicated in Chagas disease but determining its effectiveness in chronic disease is hindered by the length of time needed to demonstrate negative serological conversion. We manually reviewed long-term follow-up data from hospital records of patients with chronic Chagas disease (N = 1,4...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489720/ https://www.ncbi.nlm.nih.gov/pubmed/34606501 http://dx.doi.org/10.1371/journal.pntd.0009801 |